Thanks to a $20.6M investment from CIHR, the Canadian Consortium on Neurodegeneration in Aging is embarking on its third phase to continue important and meaningful research.
More details hereThe Canadian Consortium on Neurodegeneration in Aging (CCNA) provides the infrastructure and support that facilitates collaboration amongst Canada’s top dementia researchers and clinicians. CCNA is the premier hub for Alzheimer’s disease and dementia research in Canada, and a global leader in research on all aspects of neurodegenerative diseases from prevention to treatment to improving the quality of life of those living with the disease.
Read more
CCNA is thrilled that one of our senior dementia scientists, Dr. Kenneth Rockwood (Dalhousie University) is receiving the recognition of the Order of Canada for his major research contributions. Dr. Rockwood has been a critical member of CCNA since its inception, and we take g...
CCNA’s Partners Forum and Science Days 2024 included a Trainee poster competition. Congratulations to the four winners! Undergraduate category Vanshika Khaitan Poster title: Beyond involvement: Engaging and empowering New Brunswick older adults in brain health research ...
Thanks to a $20.6M investment from CIHR, the Canadian Consortium on Neurodegeneration in Aging is embarking on its third phase to continue important and meaningful research. The nominated principal investigator of the grant is CCNA’s Scientific Director, Dr. Howard Chert...
This Alzheimer’s Awareness Month, CCNA trainee, Laura Fitzgibbon-Collins, will lead an online story time for kids in collaboration with Let’s Talk Science (January 30th, 1 pm ET).
CCNA Team 12 members have published the first CCNA Randomized Clinical Trial showing positive effects of multidomain interventions for improving cognition in mild cognitive impairment. Read the paper here. Read the media release here.
